Use of an intronic polyadenylation site in breast cancer

Köksal Bıçakcı, Gözd
Alternative polyadenylation is an important mRNA processing step in which the length and/or the sequence of 3’UTR of mRNAs are altered. This change in 3’UTRs may have significant effects on mRNA stability, localization and translational efficiency. One of the APA types, called intronic polyadenylation (IPA), occurs on intronic sites rather than 3’UTRs. Recent evidence shows that almost 20% of human genes have a poly(A) site in at least one intron. In fact, some introns even may have more than one poly(A) site. Since generation of IPA isoforms could potentially have serious consequences on both protein levels and function, the significance of intronic APA and its occurrence is of interest. Here, we describe such an IPA site in a eukaryotic initiation factor 2B-3 (EIF2B3). Using in silico, and in vitro tools, we studied this IPA site usage in response to estrogen in ER+ breast cancer cells. We confirmed expression of EIF2B3 IPA isoform in MCF7, ER+ breast cancer cells, as well as other breast cancer cell lines and patient samples. We confirmed the usage of this intronic poly(A) site by 3’RACE, cloning and sequencing. Moreover, we showed the expression of a protein from this IPA isoform. Overall, we provide confirmatory data on an in-silico prediction of an IPA case in breast cancers. Future experiments will show the consequence of this IPA event and provide insight into similar IPA events that may happen in cancer cells.


An effort to identify novel proteins in alternative polyadenylation
Çiçek, Mustafa; Erson Bensan, Ayşe Elif; Department of Biotechnology (2020)
Polyadenylation, the addition of a poly (A) tail to a nascent messenger RNA (mRNA), is a tightly regulated process occurring co-transcriptionally. Human pre-mRNA 3’ processing complex is a multi-protein machinery: Core complexes of this machinery can be listed as; i) Cleavage and Polyadenylation Specificity Factor (CPSF), ii) Cleavage Stimulatory Factor (CSTF), and iii) Cleavage Factors Im and IIm (CFIm and CFIIm). Majority of the human genes have multiple poly(A) signals which emphasizes the significance o...
Expression of ARID3B in breast cancer cell lines
Özdemirler, Nihan; Erson Bensan, Ayşe Elif; Department of Biology (2014)
The ARID, A-T Rich Interaction Domain, is a helix-turn-helix motif based domain which binds to DNA by both sequence-specific and non-sequence specific manners. The ARID protein family is found in protozoa, green algae, higher plants, fungi and metazoans, while it is not seen in archea or eubacteria. ARID domain harboring genes are involved in variety of biological processes including embryonic development, cell lineage gene regulation, chromatin modification and cell cycle control.ARID3B, a member of ARID f...
Immunoadjuvant action of plasmid DNA in liposomes
Gürsel, Mayda; Ozkan, M; Özcengiz, Gülay (1999-03-17)
Bacterial DNA and oligodeoxynucleotides containing immunostimulatory sequences with a CpG motif stimulated a Th1 type response in vivo. The adjuvant action of a non-coding plasmid DNA derived from pRc/CMV HBS (encoding the S region of hepatitis B surface antigen, HBsAg) in mice was investigated. The role of methylation on the adjuvanticity of the plasmid as well as the effect of vaccine formulation employed on the outcome of antigen-specific humoral and cellular responses were also studied. The results demo...
ARID3B expression in primary breast cancer samples
Oğuz Erdoğan, Ayşe Selcen; Erson Bensan, Ayşe Elif; Department of Biology (2014)
ARID3B (AT-rich interaction domain 3) is a member of the family of ARID proteins, which constitutes evolutionarily conserved transcription factors implicated in normal development, differentiation, cell cycle regulation and chromatin remodeling. In addition, ARID3B has been linked to cellular immortalization, epithelial-mesenchymal transition (EMT) and tumorigenesis. Given the emerging roles of ARID3B in tumor development, we examined its expression in primary patient-derived breast cancer samples to furthe...
APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines
Onguru, Onder; Yalcin, Serap; Rosemblit, Cinthia; Zhang, Paul J.; Kilic, Selim; Gündüz, Ufuk (2016-04-01)
APOBEC3B belongs to a protein family of cytidine deaminases that can insert mutations in DNA and RNA as a result of their ability to deaminate cytidine to uridine. It has been shown that APOBEC3B-catalysed deamination provides a chronic source of DNA damage in breast cancers. We investigated APOBEC3B expression in four drug resistant breast cancer cell lines (Doxorubicin, Etoposide, Paclitaxel and Docetaxel resistant MCF-7 cell lines) using a novel RNA in situ hybridization technology (RNAscope) and compare...
Citation Formats
G. Köksal Bıçakcı, “Use of an intronic polyadenylation site in breast cancer,” Thesis (M.S.) -- Graduate School of Natural and Applied Sciences. Molecular Biology and Genetics, Middle East Technical University, 2020.